The Integrated Stress Response in Cancer: Paradox and Therapeutic Promise
Comprehensive Physiology · 2026
DOI: 10.1002/cph4.70105 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Comprehensive Physiology, 2026. Verfasst von Chenliang Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Abdominal Tumor, Department of Medical Oncology, Cancer Center, Laboratory of Abdominal Tumor Immunology and Microenvironment, West China…. Hauptthemen laut MEDLINE: Integrated Stress Response, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 263 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Sichuan Science and Technology Program, Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
The integrated stress response (ISR) is an evolutionarily conserved signaling pathway that converges diverse cellular stresses onto the eIF2α–ATF4 axis, thereby orchestrating a fundamental decision between adaptive survival and cell death. In cancer, malignant cells exploit the ISR to cope with microenvironmental pressure, yet strong or persistent ISR activation can also trigger apoptosis, highlighting its therapeutic potential. However, this duality complicates the targeting of the ISR for cancer therapy. In this review, we systematically outline the upstream regulators and downstream effector networks of the ISR, analyze its context‐dependent functions, encompassing both tumor‐promoting and tumor‐suppressing activities, in tumorigenesis, immune modulation, and therapy resistance, and evaluate the rationale for targeting the ISR under defined conditions. We also comprehensively summarize and discuss recent advances in ISR‐targeting agents, including both inhibitors and activators, under preclinical and clinical development, assessing their potential and current constraints. Although numerous challenges remain in therapeutically harnessing the ISR, we conclude that a deeper mechanistic understanding of how the ISR governs cell fate will further establish the ISR as a promising and actionable target for future cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Abdominal Tumor, Department of Medical Oncology, Cancer Center, Laboratory of Abdominal Tumor Immunology and Microenvironment, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Medical Cell Biology and Genetics, School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China.
- Division of Abdominal Tumor, Department of Medical Oncology, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Division of Abdominal Tumor, Department of Medical Oncology, Cancer Center, Laboratory of Abdominal Tumor Immunology and Microenvironment, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Che…
ORCID-Profile: Chenliang Zhang
Förderung
- National Key Research and Development Program of China
- Sichuan Science and Technology Program
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Zhang, C., Zhang, T., Tang, Q., Zeng, Y., & Cao, D. (2026). The Integrated Stress Response in Cancer: Paradox and Therapeutic Promise. Comprehensive Physiology. https://doi.org/10.1002/cph4.70105
Vancouver
Zhang C, Zhang T, Tang Q, Zeng Y, Cao D. The Integrated Stress Response in Cancer: Paradox and Therapeutic Promise. Comprehensive Physiology. 2026. doi:10.1002/cph4.70105
BibTeX
@article{Zhang2026,
author = {Zhang, Chenliang and Zhang, Ting and Tang, Qiulin and Zeng, Yu and Cao, Dan},
title = {The Integrated Stress Response in Cancer: Paradox and Therapeutic Promise},
journal = {Comprehensive Physiology},
year = {2026},
doi = {10.1002/cph4.70105}
}
EUVIMED